At a glance
ClinicalIndex Comparison RecordN/ACompleted· 79 enrolled
Drug / intervention
OCS Lung Preservationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
International Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS™) Lung For Recruiting, Preserving and Assessing Expanded Criteria Donor Lungs for Transplantation (EXPAND Trial)
In Brief
A clinical study evaluating OCS Lung Preservation for Lung Transplant. Completed, enrolled 79 participants across 11 sites in 4 countries.
Detailed Summary
To evaluate the safety and effectiveness of the OCS™ Lung to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Transplant
CountriesBelgium, Germany, Spain, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartNov 2013
Primary CompletionNov 2016
Study CompletionApr 2018
TodayJul 2026
First PostedOct 16, 2013
Enrollment StartNov 1, 2013
Primary CompletionNov 22, 2016
Study CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 12.7 years ago
Interventions
OCS Lung Preservationdevice